The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published an official update to pharmaceutical companies on preparations for Brexit.
New York City is building a biotech hub to rival South San Francisco and Boston, backed by a US$500 million finance package and a goal to quadruple the amount of R&D space in the city.
Chris Gould, managing director at Active Pharma Ideas Ltd, examines the “Brexit balancing act” between patient access to medicines, industry’s concerns and the complexities facing those negotiating.
The Indian chemicals industry, with a market size of US$145 billion is the seventh largest producer of chemicals worldwide and the third largest producer in Asia after China and Japan. According to the Chemical Industry Achievement report 2016, the market is expected to reach US$70 billion by 2020.